To optimize surgical outcomes, we are studying how combining surgery with molecular therapies can improve vision in our Molecular Surgery Program directed by Dr. Mahajan.
Combining surgery with the injections of specific molecules can improve surgical outcomes. In the Molecular Surgery Program, our surgeon and scientist teams are involved in developing gene therapies to fix faulty genes, optimizing cell transplants to replace unhealthy tissue, and using proteomic analyses of liquid biopsies to select the personalized drugs in hard to treat cases.
One area of success and continued development is investigations in the proteomic analysis of eye fluids to improve diagnostics and personalized therapies.
In addition, we apply evidence-based approaches to study and improve traditional surgery for our patients. We also translate human surgical methods into laboratory models of disease.
In all of these endeavors, our educational mission at Stanford continues to focus on providing the best possible training for surgeons and researchers in advanced surgical techniques.